论文部分内容阅读
目的分析慢性胃炎消化不良疾病使用胃铋镁与胃动力药伊托必利联合治疗的效果,提供临床治疗慢性胃炎中西治疗的依据。方法选取2014年1月~2014年6月我院的116例慢性胃炎伴消化不良患者,将患者分成对照组和观察组,均有58例。对照组使用盐酸伊托必利治疗,观察组使用胃铋镁与伊托必利联合治疗,对两组进行两2 W治疗,比较分析两组的临床治疗情况和不良反应情况。结果观察组临床症状改善显效率是43.1%,对照组是20.7%,观察组的有效率是89.7%,对照组是56.9%,P<0.05,差异具有统计学意义。此次研究没有出现不良反应病例。结论胃铋镁与胃动力药联合治疗慢性胃炎合并消化不良具有非常好的效果,患者的临床有效率较高,安全可靠。
Objective To analyze the effect of combined treatment of gastric bismuth magnesium and gastric motility drug iopride in the treatment of patients with chronic gastritis with dyspepsia and provide the basis for clinical treatment of chronic gastritis based on Chinese and western medicine. Methods From January 2014 to June 2014, 116 patients with chronic gastritis and dyspepsia in our hospital were selected and divided into control group and observation group, 58 cases in each group. The control group was treated with Itopride Hydrochloride. The observation group was treated with Combination of Bismuth Magnesium and Itopride, and the two groups were treated with two 2 W treatment. The clinical treatment and adverse reactions were compared between the two groups. Results The effective rate of clinical symptom improvement was 43.1% in observation group, 20.7% in control group, 89.7% in observation group and 56.9% in control group, P <0.05, the difference was statistically significant. There were no adverse reactions in this study. Conclusion The combination of gastric bismuth magnesium and gastric motility drug has a very good effect in the treatment of chronic gastritis complicated with dyspepsia. The clinical efficiency of the patients is high and safe.